Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vagifem 10mcg vs 25mcg in atrophic vaginitis
NCT00465192Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 1994
- Primary completion
- Nov 1995
- Modality
- Hormone, Biologic
01
Overview
A Phase 3 trial of estradiol in atrophic vaginitis, sponsored by Novo Nordisk. Started Aug 1994; status: completed.
02
Drugs
estradiol
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on NCT00465192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465192.